Drugs / Black Cohosh
Black Cohosh
also known as
Cimicifuga racemosa · Black Cohosh Extract · Klimadynon · BCE · Cimicifuga · Cimicifuga Herbarium · iCR · Phytoestrogen · +1 more
Trials 12 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00068185 | Aug 2003 → Jul 2008 | — | National Center for Complementary and Integrative Health (NCCIH) | Terminated | No outcome recorded |
| Phase 1 | NCT00010959 | Feb 2001 → Feb 2002 | — | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00064831 | Jul 2003 → Feb 2007 | — | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT03339882 | Jan → Nov 2017 | — | Zhejiang Cancer Hospital | Completed | No outcome recorded |
| Phase 2 | NCT02952742 | Nov 2016 → Nov 2018 | — | Midwestern Regional Medical Center | Withdrawn | No outcome recorded |
| Phase 2 | NCT00066144 | Apr 2003 → Apr 2006 | — | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase 2 | NCT00010712 | Sep 1999 → Jul 2005 | postmenopausal osteoporosis | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT01487694 | Dec 2011 → Oct 2012 | — | Mahidol University | Unknown | No outcome recorded |
| Phase 3 | NCT00299364 | Sep 2004 → May 2005 | — | Schaper & Bruemmer GmbH & Co KG | Completed | No outcome recorded |
| Phase 3 | NCT02184364 | Nov 1998 → Sep 2000 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00169299 | Jun 2001 → Sep 2004 | — | Kaiser Permanente | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00061711 | Jul 2000 → Dec 2005 | — | National Institute on Aging (NIA) | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02493933 Comparator | Jul → Dec 2015 | infertility disorder | Kasr El Aini Hospital | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02093650 Comparator | Mar 2014 → Mar 2016 | — | Navamindradhiraj University | Unknown | No outcome recorded |
| Phase 3 | NCT01481025 Comparator | Nov 2011 → Jun 2012 | — | Phytopharm Consulting Brazil | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02467686 Comparator | Jan 2014 → Sep 2017 | — | Irmandade da Santa Casa de Misericordia de Sao Paulo | Unknown | No outcome recorded |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 16 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | black cohosh | “Cimicifuga racemosa (black cohosh) rhizome and root extract have been used to treat menopausal symptoms.” NCT01487694 ↗7“Trifolium pratense (red clover) and Cimicifuga racemosa (black cohosh)” NCT00010959 ↗ “Cimicifuga racemosa (Black Cohosh)” NCT00061711 ↗ |
| Known as | BCE | “Black Cohosh Extract (BCE)” NCT00064831 ↗ |
| Known as | Black Cohosh Extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00064831 ↗ |
| Known as | Cimicifuga | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01481025 ↗ |
| Known as | Cimicifuga Herbarium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01481025 ↗ |
| Known as | Cimicifuga racemosa | “For centuries, black cohosh (Cimicifuga racemosa) has been used worldwide for women's health.” NCT00010712 ↗ |
| Known as | iCR | “Black Cohosh (iCR) or tibolone” NCT00299364 ↗ |
| Known as | Klimadynon | “Patients received oral PE 120 mg/ day in the form of dry coated tablets (Klimadynon, Bionorica, Germany) 2 tablets three times daily from day 1 to day 12 as adjuvant to CC in...” NCT02493933 ↗ |
| Known as | Phytoestrogen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02493933 ↗ |
| Known as | Remifemin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03339882 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “For centuries, black cohosh (Cimicifuga racemosa) has been used worldwide for women's health.” NCT00010712 ↗ |
| Route | Oral | “orally” NCT00299364 ↗ |